Billion Dollar Giants funding Research and Development is huge.
CooperVision has secured the exclusive right to co-develop EPGL advanced technologies of its choosing, with ownership of resulting intellectual property to be allocated in accordance with inventorships. EPGL has agreed to work exclusively with CooperVision in the ophthalmic and medical field to develop selected advanced technologies, granting CooperVision exclusive options to license or outright purchase EPGL’s rights to such technologies. Under the Agreement, CooperVision will fund the co-development, prototyping, manufacturing and marketing of such technologies selected by CooperVision and negotiated project by project. This Development Agreement is on-going.